Bio&Tech Smart Capital
Overview
Bio&Tech Smart Capital is a venture capital firm specializing in investments in the biotechnology and healthcare sectors, supporting innovative companies in these fields. The firm focuses on digital technologies applied to life sciences, including automation and data science, biotechnology, diagnostics, medical devices, and sustainability. It aims to transform scientific knowledge into solid and profitable companies by investing in spin-offs and startups emerging from universities, research laboratories, innovation centers, and institutions. The firm has a diversified portfolio, ensuring no single sector represents more than 50% of the invested capital. Bio&Tech Smart Capital targets a return of multiplying the invested capital over seven years. The firm is committed to responsible investment, emphasizing social impact, potential profitability, and the team's experience and knowledge of the sector. It offers support in strategy, management, and access to international markets, leveraging a network of partners in the Americas, Asia, and Europe. The team comprises professionals with extensive experience in venture capital, research, and entrepreneurship, enabling them to identify and accelerate projects with differentiating technologies and high potential. Bio&Tech Smart Capital is based in Santiago de Compostela, Spain, and operates as a closed-end fund regulated by the National Securities Market Commission (CNMV) under registration number 64. The firm has a fund size of up to 50 million euros and invests in 30-40 companies, with approximately 50% of the portfolio located in Galicia. It primarily invests in seed and Series A stages, with ticket sizes ranging from 200,000 to 400,000 euros for seed projects and 2 to 5 million euros for Series A projects, depending on achieved milestones. The firm has invested in companies such as Zerintia HealthTech, Oncostellae, and ADNTRO Genetics. Bio&Tech Smart Capital is managed by Noso Capital and promoted by Grupo Zendal and other entrepreneurs.
Investment Focus
- Digital technologies applied to life sciences (focus on automation and data science)
- Biotechnology
- Diagnostics and medical devices
- Sustainability
Portfolio Companies
Reach Bio&Tech Smart Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Bio&Tech Smart Capital
What sectors does Bio&Tech Smart Capital invest in?
Bio&Tech Smart Capital invests in HealthTech, FoodTech, Life Sciences, Digital Health, Medical Devices and Diagnostics, and is based in A Coruña, Spain. Bio&Tech Smart Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Bio&Tech Smart Capital invest at?
Bio&Tech Smart Capital backs companies at Seed and Series A, writing cheques of 200K - 5M.
Which regions does Bio&Tech Smart Capital invest in?
Bio&Tech Smart Capital invests across United States, United Kingdom, Spain and Israel.
What companies has Bio&Tech Smart Capital invested in?
Bio&Tech Smart Capital's portfolio includes Oncostellae, Zerintia HealthTech and ADNTRO Genetics.
Last updated · Source: ConnectSafely investor database




